Tonix Pharmaceuticals Holding Corp. (TNXP) stock forecast and price target
Price $3.01 · data as of November 13, 2026
12-month price target
Average target$34.00
Upside / downside+1029.6%
Analysts5
ConsensusStrong buy
Low $18.00Average $34.00High $64.00
Gold marker: average target · white marker: today’s price ($3.01)
Analyst ratings
Strong buy 0Buy 4Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-10.91 | +25.6% | $58M |
| Next fiscal year ends December 31, 2027 | $-7.00 | +35.8% | $113M |
| Next quarter ends December 31, 2026 | $-2.24 | +43.7% | $20M |
| Quarter after ends December 31, 2026 | $-2.35 | +41.0% | $23M |
Consensus of the analysts covering Tonix Pharmaceuticals Holding, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Tonix Pharmaceuticals Holding stock price target?
The average 12-month target from 5 analysts is $34.00, 1029.6% above the current price of $3.01 Targets range from $18.00 to $64.00.
Is Tonix Pharmaceuticals Holding a buy according to analysts?
The consensus rating is “Strong buy” (4 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Tonix Pharmaceuticals Holding expected to earn?
Analysts expect EPS of $-10.91 for the fiscal year ending December 31, 2026 and $-7.00 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.